POM vs EVAX
Comparison between Pomdoctor Ltd (POM, Company) and Evaxion Biotech A/S (EVAX, Company).
Both POM and EVAX are from the Healthcare sector.
POM vs EVAX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
POM
$31M
Winner
EVAX
$32M
Max Drawdown
Winner
POM
98.77%
EVAX
99.79%
Sharpe Ratio
POM
-0.00
Winner
EVAX
0.67
5Y Beta
POM
0.85
Winner
EVAX
0.76
Industry
POM
Pharmaceutical Retailers
EVAX
Biotechnology
P/E Ratio
POM
N/A
EVAX
-0.52
Forward P/E
POM
N/A
EVAX
3.57
Debt to Equity
POM
N/A
EVAX
0.00%
Free Cash Flow Yield
POM
N/A
EVAX
-21.06%
P/S Ratio
Winner
POM
0.09
EVAX
4.20
P/B Ratio
Winner
POM
-0.01
EVAX
2.14
POM vs EVAX - Historical Returns
Returns include dividend reinvestment.
1M
POM
-25.37%
Winner
EVAX
-12.71%
3M
POM
-73.52%
Winner
EVAX
-12.92%
6M
POM
-75.95%
Winner
EVAX
-41.38%
1Y
POM
N/A
EVAX
+22.56%
5Y(CAGR)
POM
N/A
EVAX
-59.76%
Max(CAGR)
POM
-99.57%
Winner
EVAX
-60.09%
POM vs EVAX - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | POM | EVAX |
|---|---|---|
| 2026 | -68.86% | -22.72% |
| 2025 | -92.68% | +3.22% |
| 2024 | N/A | -88.42% |
| 2023 | N/A | -60.59% |
| 2022 | N/A | -61.24% |
| 2021 | N/A | -55.31% |
POM vs EVAX Drawdown Comparison
The maximum drawdown for POM was -98.77%, occurring on May 8, 2026. This drawdown has not yet recovered.
The maximum drawdown for EVAX was -99.79%, occurring on Apr 21, 2025. This drawdown has not yet recovered.
The current POM drawdown is -98.33%. The current EVAX drawdown is -99.43%.
| Rank | POM | EVAX |
|---|---|---|
| #1 | -98.77% Nov 6, 2025 - May 8, 2026 | -99.79% Nov 4, 2021 - Apr 21, 2025 |
| #2 | -12.37% Oct 9, 2025 - Oct 28, 2025 | -47.74% Feb 8, 2021 - Nov 4, 2021 |
| #3 | -0.73% Oct 30, 2025 - Nov 3, 2025 | N/A |
Correlation
Correlation between POM and EVAX is 0.85 which considered as a strong positive correlation - the stocks tend to move together.
0.85
-101
Select Stocks to Compare
Popular: POM vs SPYEVAX vs SPY
More Comparisons
Compare with similar stocks